5 Recruiting Locally Advanced Bladder Urothelial Carcinoma Phase 2 Clinical Trials
Active phase 2 studies for locally advanced bladder urothelial carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Locally Advanced Bladder Urothelial Carcinoma studiesPhase 2 Studies for Locally Advanced Bladder Urothelial Carcinoma
🔵 Active, Not Recruiting Phase2
ARID1A and/or KDM6A Mutation and CXCL13 Expression
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations
📍 Los Angeles General Medical Center — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2
Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔